EMMAC Life Sciences (Curaleaf International)
About EMMAC Life Sciences (Curaleaf International)
EMMAC Life Sciences, now operating as Curaleaf International following its acquisition by Curaleaf Holdings, is one of Europe's largest independent medical cannabis companies. With operations spanning the UK, Germany, Italy, and Portugal, the company has built a pan-European platform covering cultivation, processing, and distribution. The Rome office oversees Southern European operations and Italian market development.
Key Facts
- 1Acquired by Curaleaf Holdings, one of the world's largest cannabis companies
- 2Operates in the UK, Germany, Italy, and Portugal
- 3Built through multiple acquisitions across Europe
- 4Holds EU-GMP certifications and pharmaceutical licenses in multiple countries
Frequently Asked Questions
What happened to EMMAC Life Sciences?
EMMAC Life Sciences was acquired by Curaleaf Holdings in 2021 and now operates as Curaleaf International. The company continues to expand its European medical cannabis operations under the Curaleaf banner.
In which European countries does Curaleaf International operate?
Curaleaf International has operations in the UK, Germany, Italy, and Portugal, covering cultivation, manufacturing, distribution, and clinical services across these markets.
More Cannabis Companies in Rome
Cannabis Laws
Products
- Medical cannabis flowers
- Cannabis oils and extracts
- EU-GMP pharmaceutical cannabis products
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Rome, Italy
- Founded
- 2018
- Publicly Traded
- Yes
- Ticker
- CSE:CURA